Post Operative Pain
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Published in Surgery Litigation and Law Weekly, December 26th, 2008
AcelRx Pharmaceuticals, Inc. announced positive results from a Phase 2 clinical study evaluating the safety and efficacy of its lead product candidate, ARX-01, for the treatment of moderate-to-severe inpatient acute pain following knee replacement surgery. The primary endpoint evaluated pain intensity (Sum of the Pain Intensity Difference - SPID12) over the 12-hour study period compared to baseline. Results demonstrated that compared to placebo, patients receiving 15 mcg of ARX-01 experienced a statistically significant reduction in pain intensity over the study period, based on the worst observation carried forward imputation method (WOCF), p=3D0.015. Additionally, at the 15 mcg dose, the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Surgical Technology
Encision Announces Quoting of Common Stock on the OTC Bulletin Board - Abdominal Aortic Aneurysm
New research on abdominal aortic aneurysm from G. Barbiero and co-authors summarized - Abdominal Aortic Aneurysm
Studies from H. Ishibashi and colleagues reveal new findings on abdominal aortic aneurysm - Abdominal Aortic Aneurysm Therapy
Research reports on abdominal aortic aneurysm therapy from Charite University, Center for Cardiovascular Research provide new insights - Acid Reflux Disease
Data on acid reflux disease reported by S. Bercin and co-researchers - Acne Vulgaris
Research from B. Chrastil and co-researchers yields new findings on acne vulgaris - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
